Purchase Order 75N91019P00016
Award Date 10/29/18
Potential Completion Date 10/30/19
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95112, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute issued a purchase order to Sony Biotechnology Inc. on July 1, 2026, for system maintenance services on the MH900 FP cell sorter, with a ceiling value of $135,360.00 and a firm fixed price. Performance takes place in Bethesda, Maryland. The contract covers preventative maintenance, repairs, software upgrades, and parts replacement through June 30, 2031, structured as a one-year base period followed by four one-year option periods. Sony is the sole authorized...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $19,035 purchase order to Sony Biotechnology Inc.'s San Jose, California division for maintenance services. The prime contractor, Sony Biotechnology Inc., will provide maintenance support under a firm fixed price contract running from September 21, 2023 through September 20, 2024. The award was made using the National Institutes of Health's internal funding to support the National...
- The National Cancer Institute (NCI) awarded a $40.8K firm fixed-price purchase order to Sony Biotechnology Inc. for maintenance services on the Sony ID7000 Spectral Flow Cytometer. The contract, which carries no set-aside designation, is scheduled for completion by March 1, 2027, and will be performed at the NCI facility in Bethesda, Maryland. Sony Biotechnology Inc., based in San Jose, California, is a specialized manufacturer of advanced flow cytometry and imaging instrumentation that has...
- Sony Biotechnology Inc. was awarded a $23,895 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The firm fixed price contract is for equipment maintenance services to be performed over a one year period from January 2024 through January 2025. The place of performance will be Sony Biotechnology's facility located in San Jose, California. No additional details were provided regarding the specific...
- <p>The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for $19,035.00 on September 7, 2017, with an ultimate completion date of September 20, 2018. No set-aside was used. Work is performed in Bethesda, Maryland. The order is priced on a firm fixed-price basis and procures flow cytometry instrumentation and associated support services. Sony Biotechnology operates as a prime contractor and does not use subcontractors on federal work.</p>
- The National Cancer Institute awarded a firm fixed-price purchase order to Sony Biotechnology Inc. for maintenance services on two government-owned Sony MA900 cell sorters supporting the NCI's Center for Cancer Research Vaccine Branch and Pediatric Oncology Branch. This contract covers option periods 2 and 3, with a combined ceiling value of $335,016 and an ultimate completion date of February 29, 2028. The work will be performed in Potomac, Maryland, and no small business set-aside was utilized...
- <p>The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for $19,811.78 on August 16, 2018, with performance concluding September 20, 2019. Work is performed at Bethesda, Maryland. The order is firm fixed price with no set-aside applied.</p>
- The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for $19,811.78 on September 21, 2019, with an ultimate completion date of September 20, 2020. Work is performed in Bethesda, Maryland. The order covers flow cytometry instrumentation and support services for the CCR Scientific Research Community's core facility in Building 37, which operates five cell analyzers and four additional instruments for state-of-the-art cell analysis and sorting. Pricing is firm fixed...
- The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for $311,403.80 on September 16, 2020. The order covers procurement of a Sony MA900 cell sorter with 488nm/405nm/561nm/638nm lasers, a 96/384 well plate deposition system (LE-MA900FP), and a biosafety cabinet for SH800/MA900 with AMS (BIO-02). Place of performance is San Jose, California. The order carried an ultimate completion date of December 15, 2020 and was issued on a firm fixed-price basis to de-obligate...
- <p>The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. valued at $24,957.00 on March 14, 2019, for a service agreement with a firm fixed-price structure. No set-aside was used. Performance occurs in Bethesda, Maryland. The order carried an ultimate completion date of April 17, 2020. The specific scope of services is not detailed in the source material.</p>